2-[4-[[1-(3,3-dimethylbutanoyl)piperidin-4-yl]methyl]piperazin-1-yl]-N,N-dimethylacetamide;3,3-dimethyl-1-(4-methyl-4-morpholin-4-ylpiperidin-1-yl)butan-1-one;3,3-dimethyl-1-[4-[(3-methyloxetan-3-yl)methyl]piperazin-1-yl]butan-1-one;3,3-dimethyl-1-(4-methylpiperazin-1-yl)butan-1-one;(2R)-2-(2,2-dimethylpropyl)pyrrolidine;1-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-hydroxyethyl)piperazin-1-yl]-3-methylbutan-1-one;1-[4-(3-hydroxypropyl)piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-methoxyethyl)piperazin-1-yl]-3,3-dimethylbutan-1-one

C122H239N19O16 — CID 158191673

IUPAC2-[4-[[1-(3,3-dimethylbutanoyl)piperidin-4-yl]methyl]piperazin-1-yl]-N,N-dimethylacetamide;3,3-dimethyl-1-(4-methyl-4-morpholin-4-ylpiperidin-1-yl)butan-1-one;3,3-dimethyl-1-[4-[(3-methyloxetan-3-yl)methyl]piperazin-1-yl]butan-1-one;3,3-dimethyl-1-(4-methylpiperazin-1-yl)butan-1-one;(2R)-2-(2,2-dimethylpropyl)pyrrolidine;1-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-hydroxyethyl)piperazin-1-yl]-3-methylbutan-1-one;1-[4-(3-hydroxypropyl)piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-methoxyethyl)piperazin-1-yl]-3,3-dimethylbutan-1-one
SMILESCC(C)(C)CC(=O)N1CCC(C)(N2CCOCC2)CC1.CC(C)(C)CC(=O)N1CCN(CC2(C)COC2)CC1.CC(C)(C)CC(=O)N1CCN(CCCO)CC1.CC(C)(C)CC(=O)N1CCN(CCOCCO)CC1.CC(C)(C)C[C@H]1CCCN1.CC(C)CC(=O)N1CCN(CCO)CC1.CN(C)C(=O)CN1CCN(CC2CCN(C(=O)CC(C)(C)C)CC2)CC1.CN1CCN(C(=O)CC(C)(C)C)CC1.COCCN1CCN(C(=O)CC(C)(C)C)CC1
InChIInChI=1S/C20H38N4O2.C16H30N2O2.C15H28N2O2.C14H28N2O3.2C13H26N2O2.C11H22N2O2.C11H22N2O.C9H19N/c1-20(2,3)14-18(25)24-8-6-17(7-9-24)15-22-10-12-23(13-11-22)16-19(26)21(4)5;1-15(2,3)13-14(19)17-7-5-16(4,6-8-17)18-9-11-20-12-10-18;1-14(2,3)9-13(18)17-7-5-16(6-8-17)10-15(4)11-19-12-15;1-14(2,3)12-13(18)16-6-4-15(5-7-16)8-10-19-11-9-17;1-13(2,3)11-12(16)15-7-5-14(6-8-15)9-10-17-4;1-13(2,3)11-12(17)15-8-6-14(7-9-15)5-4-10-16;1-10(2)9-11(15)13-5-3-12(4-6-13)7-8-14;1-11(2,3)9-10(14)13-7-5-12(4)6-8-13;1-9(2,3)7-8-5-4-6-10-8/h17H,6-16H2,1-5H3;5-13H2,1-4H3;5-12H2,1-4H3;17H,4-12H2,1-3H3;5-11H2,1-4H3;16H,4-11H2,1-3H3;10,14H,3-9H2,1-2H3;5-9H2,1-4H3;8,10H,4-7H2,1-3H3/t;;;;;;;;8-/m........1/s1
InChIKeyFZVIPTMZVNZNNI-NSVGXNLCSA-N
MW2228.37 g/mol
LogP11.38
Rot. Bonds30

About 2-[4-[[1-(3,3-dimethylbutanoyl)piperidin-4-yl]methyl]piperazin-1-yl]-N,N-dimethylacetamide;3,3-dimethyl-1-(4-methyl-4-morpholin-4-ylpiperidin-1-yl)butan-1-one;3,3-dimethyl-1-[4-[(3-methyloxetan-3-yl)methyl]piperazin-1-yl]butan-1-one;3,3-dimethyl-1-(4-methylpiperazin-1-yl)butan-1-one;(2R)-2-(2,2-dimethylpropyl)pyrrolidine;1-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-hydroxyethyl)piperazin-1-yl]-3-methylbutan-1-one;1-[4-(3-hydroxypropyl)piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-methoxyethyl)piperazin-1-yl]-3,3-dimethylbutan-1-one

2-[4-[[1-(3,3-dimethylbutanoyl)piperidin-4-yl]methyl]piperazin-1-yl]-N,N-dimethylacetamide;3,3-dimethyl-1-(4-methyl-4-morpholin-4-ylpiperidin-1-yl)butan-1-one;3,3-dimethyl-1-[4-[(3-methyloxetan-3-yl)methyl]piperazin-1-yl]butan-1-one;3,3-dimethyl-1-(4-methylpiperazin-1-yl)butan-1-one;(2R)-2-(2,2-dimethylpropyl)pyrrolidine;1-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-hydroxyethyl)piperazin-1-yl]-3-methylbutan-1-one;1-[4-(3-hydroxypropyl)piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-methoxyethyl)piperazin-1-yl]-3,3-dimethylbutan-1-one (PubChem CID 158191673) has the molecular formula C122H239N19O16 and a molecular weight of 2228.37 g/mol. Its IUPAC name is 2-[4-[[1-(3,3-dimethylbutanoyl)piperidin-4-yl]methyl]piperazin-1-yl]-N,N-dimethylacetamide;3,3-dimethyl-1-(4-methyl-4-morpholin-4-ylpiperidin-1-yl)butan-1-one;3,3-dimethyl-1-[4-[(3-methyloxetan-3-yl)methyl]piperazin-1-yl]butan-1-one;3,3-dimethyl-1-(4-methylpiperazin-1-yl)butan-1-one;(2R)-2-(2,2-dimethylpropyl)pyrrolidine;1-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-hydroxyethyl)piperazin-1-yl]-3-methylbutan-1-one;1-[4-(3-hydroxypropyl)piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-methoxyethyl)piperazin-1-yl]-3,3-dimethylbutan-1-one.

Molecular Properties

Compound Name2-[4-[[1-(3,3-dimethylbutanoyl)piperidin-4-yl]methyl]piperazin-1-yl]-N,N-dimethylacetamide;3,3-dimethyl-1-(4-methyl-4-morpholin-4-ylpiperidin-1-yl)butan-1-one;3,3-dimethyl-1-[4-[(3-methyloxetan-3-yl)methyl]piperazin-1-yl]butan-1-one;3,3-dimethyl-1-(4-methylpiperazin-1-yl)butan-1-one;(2R)-2-(2,2-dimethylpropyl)pyrrolidine;1-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-hydroxyethyl)piperazin-1-yl]-3-methylbutan-1-one;1-[4-(3-hydroxypropyl)piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-methoxyethyl)piperazin-1-yl]-3,3-dimethylbutan-1-one
PubChem CID158191673
Molecular FormulaC122H239N19O16
Molecular Weight2228.37 g/mol
Exact Mass2226.85
IUPAC Name2-[4-[[1-(3,3-dimethylbutanoyl)piperidin-4-yl]methyl]piperazin-1-yl]-N,N-dimethylacetamide;3,3-dimethyl-1-(4-methyl-4-morpholin-4-ylpiperidin-1-yl)butan-1-one;3,3-dimethyl-1-[4-[(3-methyloxetan-3-yl)methyl]piperazin-1-yl]butan-1-one;3,3-dimethyl-1-(4-methylpiperazin-1-yl)butan-1-one;(2R)-2-(2,2-dimethylpropyl)pyrrolidine;1-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-hydroxyethyl)piperazin-1-yl]-3-methylbutan-1-one;1-[4-(3-hydroxypropyl)piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-methoxyethyl)piperazin-1-yl]-3,3-dimethylbutan-1-one
SMILESCC(C)(C)CC(=O)N1CCC(C)(N2CCOCC2)CC1.CC(C)(C)CC(=O)N1CCN(CC2(C)COC2)CC1.CC(C)(C)CC(=O)N1CCN(CCCO)CC1.CC(C)(C)CC(=O)N1CCN(CCOCCO)CC1.CC(C)(C)C[C@H]1CCCN1.CC(C)CC(=O)N1CCN(CCO)CC1.CN(C)C(=O)CN1CCN(CC2CCN(C(=O)CC(C)(C)C)CC2)CC1.CN1CCN(C(=O)CC(C)(C)C)CC1.COCCN1CCN(C(=O)CC(C)(C)C)CC1
InChIInChI=1S/C20H38N4O2.C16H30N2O2.C15H28N2O2.C14H28N2O3.2C13H26N2O2.C11H22N2O2.C11H22N2O.C9H19N/c1-20(2,3)14-18(25)24-8-6-17(7-9-24)15-22-10-12-23(13-11-22)16-19(26)21(4)5;1-15(2,3)13-14(19)17-7-5-16(4,6-8-17)18-9-11-20-12-10-18;1-14(2,3)9-13(18)17-7-5-16(6-8-17)10-15(4)11-19-12-15;1-14(2,3)12-13(18)16-6-4-15(5-7-16)8-10-19-11-9-17;1-13(2,3)11-12(16)15-7-5-14(6-8-15)9-10-17-4;1-13(2,3)11-12(17)15-8-6-14(7-9-15)5-4-10-16;1-10(2)9-11(15)13-5-3-12(4-6-13)7-8-14;1-11(2,3)9-10(14)13-7-5-12(4)6-8-13;1-9(2,3)7-8-5-4-6-10-8/h17H,6-16H2,1-5H3;5-13H2,1-4H3;5-12H2,1-4H3;17H,4-12H2,1-3H3;5-11H2,1-4H3;16H,4-11H2,1-3H3;10,14H,3-9H2,1-2H3;5-9H2,1-4H3;8,10H,4-7H2,1-3H3/t;;;;;;;;8-/m........1/s1
InChIKeyFZVIPTMZVNZNNI-NSVGXNLCSA-N
XLogP11.38
TPSA321.59 Ų
H-Bond Donors4
H-Bond Acceptors26
Rotatable Bonds30
Heavy Atoms157
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002228.37
LogP ≤ 511.38
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1026

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-[4-[[1-(3,3-dimethylbutanoyl)piperidin-4-yl]methyl]piperazin-1-yl]-N,N-dimethylacetamide;3,3-dimethyl-1-(4-methyl-4-morpholin-4-ylpiperidin-1-yl)butan-1-one;3,3-dimethyl-1-[4-[(3-methyloxetan-3-yl)methyl]piperazin-1-yl]butan-1-one;3,3-dimethyl-1-(4-methylpiperazin-1-yl)butan-1-one;(2R)-2-(2,2-dimethylpropyl)pyrrolidine;1-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-hydroxyethyl)piperazin-1-yl]-3-methylbutan-1-one;1-[4-(3-hydroxypropyl)piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-methoxyethyl)piperazin-1-yl]-3,3-dimethylbutan-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[4-[[1-(3,3-dimethylbutanoyl)piperidin-4-yl]methyl]piperazin-1-yl]-N,N-dimethylacetamide;3,3-dimethyl-1-(4-methyl-4-morpholin-4-ylpiperidin-1-yl)butan-1-one;3,3-dimethyl-1-[4-[(3-methyloxetan-3-yl)methyl]piperazin-1-yl]butan-1-one;3,3-dimethyl-1-(4-methylpiperazin-1-yl)butan-1-one;(2R)-2-(2,2-dimethylpropyl)pyrrolidine;1-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-hydroxyethyl)piperazin-1-yl]-3-methylbutan-1-one;1-[4-(3-hydroxypropyl)piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-methoxyethyl)piperazin-1-yl]-3,3-dimethylbutan-1-one?
The IUPAC name of 2-[4-[[1-(3,3-dimethylbutanoyl)piperidin-4-yl]methyl]piperazin-1-yl]-N,N-dimethylacetamide;3,3-dimethyl-1-(4-methyl-4-morpholin-4-ylpiperidin-1-yl)butan-1-one;3,3-dimethyl-1-[4-[(3-methyloxetan-3-yl)methyl]piperazin-1-yl]butan-1-one;3,3-dimethyl-1-(4-methylpiperazin-1-yl)butan-1-one;(2R)-2-(2,2-dimethylpropyl)pyrrolidine;1-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-hydroxyethyl)piperazin-1-yl]-3-methylbutan-1-one;1-[4-(3-hydroxypropyl)piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-methoxyethyl)piperazin-1-yl]-3,3-dimethylbutan-1-one (CID 158191673) is 2-[4-[[1-(3,3-dimethylbutanoyl)piperidin-4-yl]methyl]piperazin-1-yl]-N,N-dimethylacetamide;3,3-dimethyl-1-(4-methyl-4-morpholin-4-ylpiperidin-1-yl)butan-1-one;3,3-dimethyl-1-[4-[(3-methyloxetan-3-yl)methyl]piperazin-1-yl]butan-1-one;3,3-dimethyl-1-(4-methylpiperazin-1-yl)butan-1-one;(2R)-2-(2,2-dimethylpropyl)pyrrolidine;1-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-hydroxyethyl)piperazin-1-yl]-3-methylbutan-1-one;1-[4-(3-hydroxypropyl)piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-methoxyethyl)piperazin-1-yl]-3,3-dimethylbutan-1-one.
What is the SMILES notation for 2-[4-[[1-(3,3-dimethylbutanoyl)piperidin-4-yl]methyl]piperazin-1-yl]-N,N-dimethylacetamide;3,3-dimethyl-1-(4-methyl-4-morpholin-4-ylpiperidin-1-yl)butan-1-one;3,3-dimethyl-1-[4-[(3-methyloxetan-3-yl)methyl]piperazin-1-yl]butan-1-one;3,3-dimethyl-1-(4-methylpiperazin-1-yl)butan-1-one;(2R)-2-(2,2-dimethylpropyl)pyrrolidine;1-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-hydroxyethyl)piperazin-1-yl]-3-methylbutan-1-one;1-[4-(3-hydroxypropyl)piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-methoxyethyl)piperazin-1-yl]-3,3-dimethylbutan-1-one?
The canonical SMILES for 2-[4-[[1-(3,3-dimethylbutanoyl)piperidin-4-yl]methyl]piperazin-1-yl]-N,N-dimethylacetamide;3,3-dimethyl-1-(4-methyl-4-morpholin-4-ylpiperidin-1-yl)butan-1-one;3,3-dimethyl-1-[4-[(3-methyloxetan-3-yl)methyl]piperazin-1-yl]butan-1-one;3,3-dimethyl-1-(4-methylpiperazin-1-yl)butan-1-one;(2R)-2-(2,2-dimethylpropyl)pyrrolidine;1-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-hydroxyethyl)piperazin-1-yl]-3-methylbutan-1-one;1-[4-(3-hydroxypropyl)piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-methoxyethyl)piperazin-1-yl]-3,3-dimethylbutan-1-one is CC(C)(C)CC(=O)N1CCC(C)(N2CCOCC2)CC1.CC(C)(C)CC(=O)N1CCN(CC2(C)COC2)CC1.CC(C)(C)CC(=O)N1CCN(CCCO)CC1.CC(C)(C)CC(=O)N1CCN(CCOCCO)CC1.CC(C)(C)C[C@H]1CCCN1.CC(C)CC(=O)N1CCN(CCO)CC1.CN(C)C(=O)CN1CCN(CC2CCN(C(=O)CC(C)(C)C)CC2)CC1.CN1CCN(C(=O)CC(C)(C)C)CC1.COCCN1CCN(C(=O)CC(C)(C)C)CC1.
What is the InChIKey of 2-[4-[[1-(3,3-dimethylbutanoyl)piperidin-4-yl]methyl]piperazin-1-yl]-N,N-dimethylacetamide;3,3-dimethyl-1-(4-methyl-4-morpholin-4-ylpiperidin-1-yl)butan-1-one;3,3-dimethyl-1-[4-[(3-methyloxetan-3-yl)methyl]piperazin-1-yl]butan-1-one;3,3-dimethyl-1-(4-methylpiperazin-1-yl)butan-1-one;(2R)-2-(2,2-dimethylpropyl)pyrrolidine;1-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-hydroxyethyl)piperazin-1-yl]-3-methylbutan-1-one;1-[4-(3-hydroxypropyl)piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-methoxyethyl)piperazin-1-yl]-3,3-dimethylbutan-1-one?
The InChIKey is FZVIPTMZVNZNNI-NSVGXNLCSA-N. The full InChI is InChI=1S/C20H38N4O2.C16H30N2O2.C15H28N2O2.C14H28N2O3.2C13H26N2O2.C11H22N2O2.C11H22N2O.C9H19N/c1-20(2,3)14-18(25)24-8-6-17(7-9-24)15-22-10-12-23(13-11-22)16-19(26)21(4)5;1-15(2,3)13-14(19)17-7-5-16(4,6-8-17)18-9-11-20-12-10-18;1-14(2,3)9-13(18)17-7-5-16(6-8-17)10-15(4)11-19-12-15;1-14(2,3)12-13(18)16-6-4-15(5-7-16)8-10-19-11-9-17;1-13(2,3)11-12(16)15-7-5-14(6-8-15)9-10-17-4;1-13(2,3)11-12(17)15-8-6-14(7-9-15)5-4-10-16;1-10(2)9-11(15)13-5-3-12(4-6-13)7-8-14;1-11(2,3)9-10(14)13-7-5-12(4)6-8-13;1-9(2,3)7-8-5-4-6-10-8/h17H,6-16H2,1-5H3;5-13H2,1-4H3;5-12H2,1-4H3;17H,4-12H2,1-3H3;5-11H2,1-4H3;16H,4-11H2,1-3H3;10,14H,3-9H2,1-2H3;5-9H2,1-4H3;8,10H,4-7H2,1-3H3/t;;;;;;;;8-/m........1/s1.
What are the key properties of 2-[4-[[1-(3,3-dimethylbutanoyl)piperidin-4-yl]methyl]piperazin-1-yl]-N,N-dimethylacetamide;3,3-dimethyl-1-(4-methyl-4-morpholin-4-ylpiperidin-1-yl)butan-1-one;3,3-dimethyl-1-[4-[(3-methyloxetan-3-yl)methyl]piperazin-1-yl]butan-1-one;3,3-dimethyl-1-(4-methylpiperazin-1-yl)butan-1-one;(2R)-2-(2,2-dimethylpropyl)pyrrolidine;1-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-hydroxyethyl)piperazin-1-yl]-3-methylbutan-1-one;1-[4-(3-hydroxypropyl)piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-methoxyethyl)piperazin-1-yl]-3,3-dimethylbutan-1-one?
2-[4-[[1-(3,3-dimethylbutanoyl)piperidin-4-yl]methyl]piperazin-1-yl]-N,N-dimethylacetamide;3,3-dimethyl-1-(4-methyl-4-morpholin-4-ylpiperidin-1-yl)butan-1-one;3,3-dimethyl-1-[4-[(3-methyloxetan-3-yl)methyl]piperazin-1-yl]butan-1-one;3,3-dimethyl-1-(4-methylpiperazin-1-yl)butan-1-one;(2R)-2-(2,2-dimethylpropyl)pyrrolidine;1-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-hydroxyethyl)piperazin-1-yl]-3-methylbutan-1-one;1-[4-(3-hydroxypropyl)piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-methoxyethyl)piperazin-1-yl]-3,3-dimethylbutan-1-one has a molecular weight of 2228.37 g/mol, XLogP of 11.38, 30 rotatable bonds, 4 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[[1-(3,3-dimethylbutanoyl)piperidin-4-yl]methyl]piperazin-1-yl]-N,N-dimethylacetamide;3,3-dimethyl-1-(4-methyl-4-morpholin-4-ylpiperidin-1-yl)butan-1-one;3,3-dimethyl-1-[4-[(3-methyloxetan-3-yl)methyl]piperazin-1-yl]butan-1-one;3,3-dimethyl-1-(4-methylpiperazin-1-yl)butan-1-one;(2R)-2-(2,2-dimethylpropyl)pyrrolidine;1-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-hydroxyethyl)piperazin-1-yl]-3-methylbutan-1-one;1-[4-(3-hydroxypropyl)piperazin-1-yl]-3,3-dimethylbutan-1-one;1-[4-(2-methoxyethyl)piperazin-1-yl]-3,3-dimethylbutan-1-one is sourced from PubChem (CID 158191673), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).